| scholarly article | Q13442814 |
| P50 | author | Massimo Serra | Q38549348 |
| P2093 | author name string | Comoglio PM | |
| Baldini N | |||
| Oliviero M | |||
| Manara MC | |||
| Scotlandi K | |||
| Di Renzo MF | |||
| Ferracini R | |||
| Martano M | |||
| P2860 | cites work | Identification of the Hepatocyte Growth Factor Receptor As the c- met Proto-Oncogene Product | Q24310794 |
| Extracellular proteolytic cleavage by urokinase is required for activation of hepatocyte growth factor/scatter factor | Q24555664 | ||
| Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications | Q24561689 | ||
| Scatter factor and hepatocyte growth factor are indistinguishable ligands for the MET receptor | Q24564783 | ||
| Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 | Q25938983 | ||
| Molecular cloning and sequence analysis of the cDNA for a human serine protease reponsible for activation of hepatocyte growth factor. Structural similarity of the protease precursor to blood coagulation factor XII | Q28115845 | ||
| Structure, biosynthesis and biochemical properties of the HGF receptor in normal and malignant cells | Q28262825 | ||
| Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice | Q29547898 | ||
| Mechanisms of p53 loss in human sarcomas | Q33722859 | ||
| Invasiveness and metastasis of NIH 3T3 cells induced by Met-hepatocyte growth factor/scatter factor autocrine stimulation | Q35277738 | ||
| Hepatocyte growth factor and its receptor (c-MET) in prostatic carcinoma | Q35796063 | ||
| Transfer of motogenic and invasive response to scatter factor/hepatocyte growth factor by transfection of human MET protooncogene | Q36065558 | ||
| Scatter factor induces blood vessel formation in vivo | Q36141804 | ||
| Scatter factor: molecular characteristics and effect on the invasiveness of epithelial cells | Q36223889 | ||
| Enhanced tumorigenicity and invasion-metastasis by hepatocyte growth factor/scatter factor-met signalling in human cells concomitant with induction of the urokinase proteolysis network | Q36557528 | ||
| Tumorigenicity of the met proto-oncogene and the gene for hepatocyte growth factor | Q36705281 | ||
| Characterization of the TPR-MET oncogene p65 and the MET protooncogene p140 protein-tyrosine kinases | Q37479257 | ||
| Osteosarcoma: fifteen years later | Q39835579 | ||
| Hepatocyte growth factor/scatter factor and its receptor, the c-met proto-oncogene product | Q40794270 | ||
| Inducibility of neoplastic transformation by Fujinami sarcoma virus in an in vitro chick embryo model for osteosarcoma: (i) effect of differentiation and (ii) investigation for in vivo growth potential in athymic mice | Q41132152 | ||
| Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth | Q41596252 | ||
| Identification of a fibroblast-derived epithelial morphogen as hepatocyte growth factor | Q41656206 | ||
| Expression of the Met/HGF receptor in normal and neoplastic human tissues | Q41658755 | ||
| c-met is amplified but not mutated in a cell line with an activated met tyrosine kinase | Q41690281 | ||
| p53 expression and its relationship to DNA alterations in bone and soft tissue sarcomas | Q42281236 | ||
| The receptor encoded by the human c-MET oncogene is expressed in hepatocytes, epithelial cells and solid tumors | Q42473244 | ||
| Scatter factor/hepatocyte growth factor and its receptor, the c-met tyrosine kinase, can mediate a signal exchange between mesenchyme and epithelia during mouse development | Q42770153 | ||
| Met expression and sarcoma tumorigenicity | Q42804653 | ||
| Scatter factor is a fibroblast-derived modulator of epithelial cell mobility | Q42807925 | ||
| Tyrosine kinase receptor indistinguishable from the c-met protein | Q42814654 | ||
| Met proto-oncogene product is overexpressed in tumors of p53-deficient mice and tumors of Li-Fraumeni patients. | Q42828029 | ||
| Giant-cell tumor of bone | Q43856120 | ||
| Molecular cloning of a new transforming gene from a chemically transformed human cell line. | Q45345810 | ||
| Hepatocyte growth factor/hepatopoietin A stimulates the growth of rat kidney proximal tubule epithelial cells (RPTE), rat nonparenchymal liver cells, human melanoma cells, mouse keratinocytes and stimulates anchorage-independent growth of SV-40 tran | Q45350288 | ||
| Overexpression of the c-MET/HGF receptor gene in human thyroid carcinomas | Q48146638 | ||
| Amplification of both c-myc and c-raf-1 oncogenes in a human osteosarcoma. | Q55237135 | ||
| c-fos expression induces bone tumors in transgenic mice | Q58326983 | ||
| The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene | Q59092154 | ||
| Sequestration of a hepatocyte growth factor in extracellular matrix in normal adult rat liver | Q67897413 | ||
| Lung may have an endocrine function producing hepatocyte growth factor in response to injury of distal organs | Q68052543 | ||
| Biosynthesis of the protein encoded by the c-met proto-oncogene | Q69359093 | ||
| Studies of the retinoblastoma gene in human sarcomas | Q69670170 | ||
| Expression of c-sis and other cellular proto-oncogenes in human sarcoma cell lines and biopsies | Q69751078 | ||
| The Met/HGF receptor is over-expressed in human osteosarcomas and is activated by either a paracrine or an autocrine circuit | Q72560868 | ||
| Expression of the Met/hepatocyte growth factor receptor in human pancreatic cancer | Q72571222 | ||
| Sporadic amplification of the MYC gene in human osteosarcomas | Q72721753 | ||
| Overexpression and amplification of the met/HGF receptor gene during the progression of colorectal cancer | Q77555522 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1209-1219 | |
| P577 | publication date | 1996-10-01 | |
| P1433 | published in | The American Journal of Pathology | Q4744259 |
| P1476 | title | Expression of Met/hepatocyte growth factor receptor gene and malignant behavior of musculoskeletal tumors | |
| P478 | volume | 149 |
| Q47303095 | Activated HGF-c-Met Axis in Head and Neck Cancer |
| Q35082747 | Acute tissue injury activates satellite cells and promotes sarcoma formation via the HGF/c-MET signaling pathway |
| Q52665713 | Cabozantinib Affects Osteosarcoma Growth Through A Direct Effect On Tumor Cells and Modifications In Bone Microenvironment. |
| Q34700590 | Defective osteogenic differentiation in the development of osteosarcoma |
| Q42555042 | Epithelial-to-mesenchymal and mesenchymal-to-epithelial transitions in the colon |
| Q33275985 | Establishment of clival chordoma cell line MUG-CC1 and lymphoblastoid cells as a model for potential new treatment strategies |
| Q28817274 | Exploring targeted therapy of osteosarcoma using proteomics data |
| Q74453712 | Expression of Hepatocyte Growth Factor (HGF) and its Receptor (MET) in Medullary Carcinoma of the Thyroid |
| Q37306012 | Expression of Ovol2 is related to epithelial characteristics and shows a favorable clinical outcome in hepatocellular carcinoma |
| Q41908214 | Human Chondrosarcoma Cells Acquire an Epithelial-Like Gene Expression Pattern via an Epigenetic Switch: Evidence for Mesenchymal-Epithelial Transition during Sarcomagenesis. |
| Q79269259 | Impact of c-Met expression on angiogenesis in soft tissue sarcomas: correlation to microvessel-density |
| Q37201330 | MET and autism susceptibility: family and case-control studies |
| Q43201388 | Non-autocrine, constitutive activation of Met in human anaplastic thyroid carcinoma cells in culture |
| Q37263375 | Novel targets with potential therapeutic applications in osteosarcoma |
| Q36803600 | Osteosarcoma development and stem cell differentiation |
| Q42279434 | Overexpression of the hepatocyte growth factor (HGF) receptor (Met) and presence of a truncated and activated intracellular HGF receptor fragment in locally aggressive/malignant human musculoskeletal tumors. |
| Q28538117 | Separate and combined effects of DNMT and HDAC inhibitors in treating human multi-drug resistant osteosarcoma HosDXR150 cell line |
| Q36514299 | The Current and Future Therapies for Human Osteosarcoma |
| Q36194212 | Tumor-Activated Mesenchymal Stromal Cells Promote Osteosarcoma Stemness and Migratory Potential via IL-6 Secretion. |
| Q47588979 | c-Met tyrosine kinase receptor expression and function in human and canine osteosarcoma cells |
Search more.